Jerome Ritz

65PUBLICATIONS
330CO-AUTHORS
Molecular targetsRegenerative medicine (incl. stem cells)Respiratory diseasesGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (65)

|Sep 29, 2026
Spatially confined IL-12 programs CAR-NK through mTORC1 to coordinate antitumor immune networks.

|Sep 12, 2026
Teclistamab versus lenalidomide-dexamethasone in high-risk smoldering multiple myeloma: a randomized phase 2 trial.

|Jun 03, 2026
Long-term stability of posttranscriptional genetic silencing of BCL11A using a shmiR vector in sickle cell disease.

|May 27, 2026
Efficacy and safety of durcabtagene autoleucel in a phase 1 trial for patients with relapsed/refractory multiple myeloma.

|Apr 30, 2026
Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host Disease.

|Apr 20, 2026
Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trial.

Pageof 11

Frequent Collaborators

10 joint publications

Katie Maurer

8 joint publications

Catherine J Wu

7 joint publications

Livius Penter

7 joint publications

Kenneth J Livak